의료기기 시장 : 유형별, 용도별, 지역별 규모, 점유율 및 성장률, 산업 분석, 인사이트 및 예측(2026-2034년)

Medical Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

US $ 4,850 ￦ 7,227,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 및 편집이 불가능합니다.

US $ 5,850 ￦ 8,718,000

Unprintable PDF & Excel (Multi User License)

PDF & Excel 보고서를 동일 기업의 6명까지 이용할 수 있는 라이선스입니다. 인쇄 및 편집이 불가능합니다. 보고서 내 텍스트 등의 복사 및 붙여넣기는 가능합니다.

US $ 6,850 ￦ 10,208,000

PDF, Excel & PPT (Enterprise License)

PDF, Excel & PPT 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 및 편집이 가능하며, 보고서 내 텍스트 등의 복사 및 붙여넣기도 가능합니다.

한글목차

의료기기 시장의 성장요인

세계의 의료기기 시장은 질병 부담 증가, 기술 혁신, 진단 및 치료 솔루션에 대한 접근성 확대에 의해 현대 의료에서 가장 중요한 기둥 중 하나를 형성하고 있습니다. 보고서에 따르면 2025년 의료기기 시장의 규모는 5,723억 1,000만 달러로 평가되었습니다. 고급 진단 툴, 수술 기구, 웨어러블 기술의 채택 확대에 따라 시장의 규모는 2026년에는 6,049억 9,000만 달러에 달할 것으로 예측되고 있습니다. 장기 예측기간에서는 지속적인 기술 혁신과 의료 수요 증가로 시장의 규모는 2034년까지 1조 326억 6,000만 달러에 달할 것으로 전망되고 있으며, 이는 세계 시장의 견조하고 지속적인 확대를 반영하고 있습니다.

의료기기에는 진단용 영상 시스템, 체외진단제, 순환기 장치, 정형외과용 임플란트, 당뇨병 관리기기, 수술용 기구, 웨어러블 건강 모니터 등 다양한 제품이 포함됩니다. 당뇨병, 심혈관질환, 암, 신경질환 등의 만성 및 급성질환의 유병률 증가에 의해 환자의 진단 및 치료용 의료기기에 대한 의존도가 대폭 상승하고 있습니다. 조기 진단과 치료 옵션에 대한 인식 향상은 세계의 진단 검사 및 수술 증가를 더욱 뒷받침하고 있습니다.

시장 역학

의료기기 산업의 성장을 견인하는 주요 요인은 만성질환의 증가와 고령화 사회의 진전입니다. 세계적으로 장기적인 질병 관리를 필요로 하는 환자 수가 증가하고 있으며, 모니터링 장비, 영상 진단 시스템 및 치료 장비에 대한 수요가 증가하고 있습니다. 특히 고령화 인구의 확대는 정형외과용 기기, 안과용 기기, 순환기용 기기, 재택 치료기기의 수요 증가에 기여하고 있습니다.

또 다른 중요한 성장요인은 연구 개발에 대한 투자 증가입니다. 주요 제조업체는 기술적으로 선진적인 저침습성 환자 중심 솔루션 개발에 주력하고 있습니다. 선진국 시장에서는 획기적인 장비 지정과 신속한 규제 경로가 혁신을 가속화하고 있습니다. 메드트로닉과 존슨 앤드 존슨 서비스와 같은 기업들은 미충족 임상 요구에 대응하기 위해 차세대 의료 기술에 대한 대규모 투자를 지속하고 있습니다.

그러나 선진 의료기기의 높은 비용과 개발도상국의 불충분한 환급정책에 의해 시장에는 제약도 발생하고 있습니다. MRI 스캐너, CT 스캐너, 로봇 수술 시스템과 같은 자본 집약형 장비는 신흥 경제국의 대부분의 의료시설에서 여전히 도입하기 어렵습니다. 게다가, 첨단 처치에 대한 환급 범위의 제한은 가격에 민감한 시장에서의 도입을 방해합니다.

시장 기회 및 과제

의료기기 시장은 R&D 투자 증가와 신흥 시장 진출을 통해 강력한 성장 기회를 제공합니다. 아시아태평양, 라틴아메리카, 중동 및 아프리카의 의료비 증가, 인프라 개선, 정부의 의료 근대화에 대한 주력 강화가 새로운 성장 경로를 형성하고 있습니다. 재택 치료나 휴대형 의료기기로의 전환도 시장 확대를 더욱 뒷받침하고 있습니다.

한편, 엄격하고 진화하는 규제 프레임워크는 과제가 되고 있습니다. 제조업체는 각 지역마다 다른 규제 기준에 대응해야 하며 승인까지의 기간과 규정 준수 비용이 증가하고 있습니다. 무역보호주의와 지정학적 긴장은 특히 국경을 넘는 의료기기 거래에서 공급망과 시장 접근에 영향을 미칩니다.

시장 동향

의료기기 업계를 형성하는 현저한 동향으로는 웨어러블 기기 및 원격 모니터링 기기에 대한 수요 증가를 들 수 있습니다. 건강 의식 증가와 디지털 건강 도입의 진전으로 스마트 워치, 피트니스 트래커, 원격 진단 도구에 대한 수요가 촉진되고 있습니다. 이러한 장비는 지속적인 건강 모니터링과 질병의 조기 발견을 가능하게 하여 예방 의료 모델을 뒷받침합니다.

기타 현저한 동향으로는 맞춤형 의료의 대두, 진단 및 영상 진단에서의 인공지능 활용 확대, 입원 기간의 단축과 환자 결과의 개선으로 이어지는 저침습 수술에 대한 수요 증가 등을 들 수 있습니다.

부문별 분석

유형별로는 2025년 체외진단제(IVD)가 가장 높은 시장 점유율을 차지했습니다. 이는 대량의 임상 진단 검사 실시와 감염증 및 만성질환의 유병률 상승에 의한 결과입니다. 당뇨병 관리기기와 저침습 수술기기도 질병 부담 증가와 수술 건수 증가에 의해 강한 성장을 보이고 있습니다.

최종 사용자별로는 2026년 병원 및 외래수술센터(ASC)가 시장을 독점할 전망입니다. 이는 많은 환자 유입과 고급 장비의 가용성 및 다전문 의료시설의 확대가 주요 요인입니다.

지역별 전망

북미는 첨단 의료 인프라, 유리한 환급 정책, 혁신 기술의 급속한 도입에 힘입어 2025년 38.1%의 점유율로 의료기기 시장을 선도했습니다. 유럽은 견고한 규제 체제와 재택 치료의 보급 확대로 인해 여전히 중요한 시장입니다. 아시아태평양은 중국, 인도, 일본 등의 국가에서 급증하는 환자 수, 증가하는 의료 투자, 확대하는 제조 능력에 의해 고성장 지역으로 대두되고 있습니다.

한편, 장비의 높은 비용, 개발도상지역의 환급 제한, 복잡한 규제 프레임워크는 여전히 주요 과제이지만, 연구개발에 대한 지속적인 투자, 급속한 혁신, 신흥 시장으로의 확대가 새로운 성장 기회를 창출하고 있습니다. 북미의 리더십, 유럽의 꾸준한 발전, 아시아태평양의 높은 성장세는 균형잡힌 세계의 확대를 보이고 있습니다. 전반적으로, 본 보고서의 대상연도인 2025년, 2026년, 2034년을 통해 의료기기 시장은 회복력과 혁신성을 유지하고, 세계의 환자 예후 개선 및 의료 시스템 강화에 중심적인 역할을 할 것으로 예측됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 역학

• 촉진요인
• 억제요인
• 시장 기회

제4장 주요 인사이트

• 주요국의 의료 지출 개요(2024 및 2025년)
• 주요 기업의 COVID-19 관련 신제품 출시 상황
• 최근 업계 동향 : 기업 합병 및 인수(M&A)
• 기술진보
• 주요 업계 동향
• COVID-19가 의료기기 시장에 미치는 영향

제5장 세계의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 시장 분석, 인사이트 및 예측 : 유형별
  • 정형외과용 기기
  • 순환기용 기기
  • 영상 진단기기
  • 체외진단제(IVD)
  • 저침습 수술기기
  • 상처 관리
  • 당뇨병 관리기기
  • 안과용 기기
  • 신장병 치료기기
  • 치과용 기기
  • 일반 외과용 기기
  • 기타
• 시장 분석, 인사이트 및 예측 : 최종 사용자별
  • 병원 및 외래수술센터(ASC)
  • 진료소
  • 기타
• 시장 분석, 인사이트 및 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제6장 북미의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 국가별
  • 미국
  • 캐나다

제7장 유럽의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 국가별
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽

제8장 아시아태평양의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 국가별
  • 중국
  • 일본
  • 인도
  • 호주
  • 기타 아시아태평양

제9장 라틴아메리카의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 국가별
  • 브라질
  • 멕시코
  • 기타 라틴아메리카

제10장 중동 및 아프리카의 의료기기 시장 분석 : 인사이트 및 예측(2021-2034년)

• 국가별
  • 걸프협력회의(GCC) 국가
  • 남아프리카
  • 기타 중동 및 아프리카

제11장 COVID-19에 의한 고, 중, 저수준 영향 분석

• 의료기기 시장
  • 고수준 영향
  • 중간수준 영향
  • 저수준 영향
• 주요 의료기기 기업
  • 고수준 영향
  • 중간수준 영향
  • 저수준 영향

제12장 경쟁 분석

• 세계 시장 점유율 분석(2025년)
• 시장의 주요 활동 기업 : 개요
  • Medtronic
  • Abbott
  • Siemens Healthineers AG
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Stryker
  • F. Hoffmann-La Roche AG
  • BD
  • GE Healthcare
  • Boston Scientific Corporation
  • Fresenius Medical Care AG & Co. KGaA

CSM

영문 목차

영문목차

Growth Factors of medical devices Market

The global medical devices market represents one of the most critical pillars of modern healthcare, driven by rising disease burden, technological innovation, and expanding access to diagnostic and therapeutic solutions. According to the report timeline, the medical devices market size was valued at USD 572.31 billion in 2025. With increasing adoption of advanced diagnostic tools, surgical instruments, and wearable technologies, the market is projected to reach USD 604.99 billion in 2026. Over the long-term forecast period, continued innovation and growing healthcare demand are expected to push the market to USD 1,032.66 billion by 2034, reflecting strong and sustained global expansion.

Medical devices include a wide range of products such as diagnostic imaging systems, in-vitro diagnostics, cardiovascular devices, orthopedic implants, diabetes care devices, surgical instruments, and wearable health monitors. The increasing prevalence of chronic and acute diseases such as diabetes, cardiovascular disorders, cancer, and neurological conditions has significantly increased patient reliance on diagnostic and interventional medical devices. Rising awareness of early diagnosis and treatment options has further fueled the volume of diagnostic tests and surgical procedures worldwide.

Market Dynamics

A key driver of growth in the medical devices industry is the rising prevalence of chronic diseases and aging population. Globally, the number of patients requiring long-term disease management is increasing, leading to higher demand for monitoring devices, imaging systems, and therapeutic equipment. The expanding geriatric population is particularly contributing to demand for orthopedic, ophthalmic, cardiovascular, and home healthcare devices.

Another important growth factor is increasing investment in research and development. Major manufacturers are focusing on developing technologically advanced, minimally invasive, and patient-centric solutions. Breakthrough device designations and faster regulatory pathways in developed markets are accelerating innovation. Companies such as Medtronic and Johnson & Johnson Services, Inc. continue to invest heavily in next-generation medical technologies to address unmet clinical needs.

However, the market faces restraints due to high costs of advanced medical devices and inadequate reimbursement policies in developing countries. Capital-intensive equipment such as MRI scanners, CT scanners, and robotic surgery systems remain inaccessible to many healthcare facilities in emerging economies. Additionally, limited reimbursement coverage for advanced procedures restricts adoption in price-sensitive markets.

Market Opportunities and Challenges

The medical devices market presents strong opportunities through increased R&D investments and expansion into emerging markets. Rising healthcare expenditure, improving infrastructure, and growing government focus on healthcare modernization in Asia Pacific, Latin America, and the Middle East & Africa are creating new growth avenues. The shift toward home healthcare and portable medical devices further supports market expansion.

At the same time, stringent and evolving regulatory frameworks pose challenges. Manufacturers must comply with diverse regulatory standards across regions, increasing approval timelines and compliance costs. Trade protectionism and geopolitical tensions also impact supply chains and market access, particularly for cross-border medical device trade.

Market Trends

A prominent trend shaping the medical devices industry is the growing preference for wearable and remote monitoring devices. Increasing health consciousness and digital health adoption have driven demand for smartwatches, fitness trackers, and remote diagnostic tools. These devices enable continuous health monitoring and early detection, supporting preventive healthcare models.

Other notable trends include the rise of personalized medicine, increasing use of artificial intelligence in diagnostics and imaging, and growing demand for minimally invasive surgical procedures that reduce hospital stays and improve patient outcomes.

Segmentation Insights

By type, in-vitro diagnostics (IVD) held the largest market share in 2025, supported by the high volume of clinical diagnostic tests and rising infectious and chronic disease prevalence. Diabetes care devices and minimally invasive surgery devices are also experiencing strong growth due to increasing disease burden and procedural volumes.

By end-user, hospitals and ambulatory surgery centers (ASCs) dominated the market in 2026, driven by high patient inflow, availability of advanced equipment, and expansion of multispecialty healthcare facilities.

Regional Outlook

North America dominated the medical devices market with a 38.1% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of innovative technologies. Europe remains a significant market due to strong regulatory frameworks and growing home healthcare adoption. Asia Pacific is emerging as a high-growth region, driven by large patient populations, rising healthcare investments, and expanding manufacturing capabilities in countries such as China, India, and Japan.

Competitive Landscape

The global medical devices market is fragmented, with key players such as GE Healthcare, Stryker, Abbott, and Siemens Healthineers AG focusing on product innovation, acquisitions, and geographic expansion. Strategic collaborations, regulatory approvals, and portfolio diversification remain central to maintaining competitive advantage.

Aligned strictly with the report years 2025, 2026, and 2034, the medical devices industry is set to expand steadily, supported by rising healthcare demand, continuous technological advancement, and increasing global focus on early diagnosis, effective treatment, and patient-centric care.

Conclusion

The global medical devices industry is positioned for consistent and long-term growth, supported by rising healthcare demand, technological advancement, and expanding access to diagnostic and therapeutic solutions. Valued at USD 572.31 billion in 2025, the market's progression to USD 604.99 billion in 2026 reflects strong adoption of advanced diagnostic tools, minimally invasive surgical systems, and wearable health technologies. The projected expansion to USD 1,032.66 billion by 2034 underscores the industry's critical role in addressing the growing burden of chronic diseases and an aging global population.

While high device costs, reimbursement limitations in developing regions, and complex regulatory frameworks remain key challenges, sustained investments in research and development, rapid innovation, and expansion into emerging markets continue to create new growth opportunities. Regional leadership by North America, steady advancement in Europe, and high-growth momentum in Asia Pacific indicate a well-balanced global expansion. Overall, aligned strictly with the report years 2025, 2026, and 2034, the medical devices market is expected to remain resilient and innovation-driven, playing a central role in improving patient outcomes and strengthening healthcare systems worldwide.

Segmentation By Type

• Orthopedic Devices
• Cardiovascular Devices
• Diagnostic Imaging Devices
• In-vitro Diagnostic (IVD)
• Minimally Invasive Surgery Devices
• Wound Management
• Diabetes Care Devices
• Ophthalmic Devices
• Dental Devices
• Nephrology Devices
• General Surgery
• Others

By End-User

• Hospitals & ASCs
• Clinics
• Others

By Region

• North America (By Type, End-User, and Country)
  • U.S. (By Type and End-User)
  • Canada (By Type and End-User)
• Europe (By Type, End-User, and Country/Sub-region)
  • U.K. (By Type and End-User)
  • Germany (By Type and End-User)
  • France (By Type and End-User)
  • Italy (By Type and End-User)
  • Spain (By Type and End-User)
  • Rest of Europe (By Type and End-User)
• Asia Pacific (By Type, End-User, and Country/Sub-region)
  • China (By Type and End-User)
  • Japan (By Type and End-User)
  • India (By Type and End-User)
  • Australia (By Type and End-User)
  • Rest of Asia Pacific (By Type and End-User)
• Latin America (By Type, End-User, and Country/Sub-region)
  • Brazil (By Type and End-User)
  • Mexico (By Type and End-User)
  • Rest of Latin America (By Type and End-User)
• Middle East & Africa (By Type, End-User, and Country/ Sub-region)
  • GCC (By Type and End-User)
  • South Africa (By Type and End-User)
• Rest of Middle East & Africa (By Type and End-User)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Overview of Healthcare Expenditure by Key Countries, 2024/2025
• 4.2. New Product Launches, by Key Players for COVID-19
• 4.3. Recent Industry Developments - Mergers & Acquisitions
• 4.4. Technological Advancements
• 4.5. Key Industry Trends
• 4.6. Impact of COVID-19 on the Medical Devices Market

5. Global Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Orthopedic Devices
  • 5.1.2. Cardiovascular Devices
  • 5.1.3. Diagnostic Imaging Devices
  • 5.1.4. In-vitro Diagnostics (IVD)
  • 5.1.5. Minimally Invasive Surgery Devices
  • 5.1.6. Wound Management
  • 5.1.7. Diabetes Care Devices
  • 5.1.8. Ophthalmic Devices
  • 5.1.9. Nephrology Devices
  • 5.1.10. Dental Devices
  • 5.1.11. General Surgery
  • 5.1.12. Others
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Hospitals & ASCs
  • 5.2.2. Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Geography
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Orthopedic Devices
  • 6.1.2. Cardiovascular Devices
  • 6.1.3. Diagnostic Imaging Devices
  • 6.1.4. In-vitro Diagnostics (IVD)
  • 6.1.5. Minimally Invasive Surgery Devices
  • 6.1.6. Wound Management
  • 6.1.7. Diabetes Care Devices
  • 6.1.8. Ophthalmic Devices
  • 6.1.9. Nephrology Devices
  • 6.1.10. Dental Devices
  • 6.1.11. General Surgery
  • 6.1.12. Others
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Hospitals & ASCs
  • 6.2.2. Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. U.S. Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 6.4.1. Market Analysis, Insights and Forecast - By Type
    • 6.4.1.1. Orthopedic Devices
    • 6.4.1.2. Cardiovascular Devices
    • 6.4.1.3. Diagnostic Imaging Devices
    • 6.4.1.4. In-vitro Diagnostics (IVD)
    • 6.4.1.5. Minimally Invasive Surgery Devices
    • 6.4.1.6. Wound Management
    • 6.4.1.7. Diabetes Care Devices
    • 6.4.1.8. Ophthalmic Devices
    • 6.4.1.9. Nephrology Devices
    • 6.4.1.10. Dental Devices
    • 6.4.1.11. General Surgery
    • 6.4.1.12. Others
  • 6.4.2. Market Analysis, Insights and Forecast - By End User
    • 6.4.2.1. Hospitals & ASCs
    • 6.4.2.2. Clinics
    • 6.4.2.3. Others
• 6.5. Canada Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 6.5.1. Market Analysis, Insights and Forecast - By Type
    • 6.5.1.1. Orthopedic Devices
    • 6.5.1.2. Cardiovascular Devices
    • 6.5.1.3. Diagnostic Imaging Devices
    • 6.5.1.4. In-vitro Diagnostics (IVD)
    • 6.5.1.5. Minimally Invasive Surgery Devices
    • 6.5.1.6. Wound Management
    • 6.5.1.7. Diabetes Care Devices
    • 6.5.1.8. Ophthalmic Devices
    • 6.5.1.9. Nephrology Devices
    • 6.5.1.10. Dental Devices
    • 6.5.1.11. General Surgery
    • 6.5.1.12. Others
  • 6.5.2. Market Analysis, Insights and Forecast - By End User
    • 6.5.2.1. Hospitals & ASCs
    • 6.5.2.2. Clinics
    • 6.5.2.3. Others

7. Europe Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Orthopedic Devices
  • 7.1.2. Cardiovascular Devices
  • 7.1.3. Diagnostic Imaging Devices
  • 7.1.4. In-vitro Diagnostics (IVD)
  • 7.1.5. Minimally Invasive Surgery Devices
  • 7.1.6. Wound Management
  • 7.1.7. Diabetes Care Devices
  • 7.1.8. Ophthalmic Devices
  • 7.1.9. Nephrology Devices
  • 7.1.10. Dental Devices
  • 7.1.11. General Surgery
  • 7.1.12. Others
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Hospitals & ASCs
  • 7.2.2. Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Rest of Europe
• 7.4. U.K. Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.4.1. Market Analysis, Insights and Forecast - By Type
    • 7.4.1.1. Orthopedic Devices
    • 7.4.1.2. Cardiovascular Devices
    • 7.4.1.3. Diagnostic Imaging Devices
    • 7.4.1.4. In-vitro Diagnostics (IVD)
    • 7.4.1.5. Minimally Invasive Surgery Devices
    • 7.4.1.6. Wound Management
    • 7.4.1.7. Diabetes Care Devices
    • 7.4.1.8. Ophthalmic Devices
    • 7.4.1.9. Nephrology Devices
    • 7.4.1.10. Dental Devices
    • 7.4.1.11. General Surgery
    • 7.4.1.12. Others
  • 7.4.2. Market Analysis, Insights and Forecast - By End User
    • 7.4.2.1. Hospitals & ASCs
    • 7.4.2.2. Clinics
    • 7.4.2.3. Others
• 7.5. Germany Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.5.1. Market Analysis, Insights and Forecast - By Type
    • 7.5.1.1. Orthopedic Devices
    • 7.5.1.2. Cardiovascular Devices
    • 7.5.1.3. Diagnostic Imaging Devices
    • 7.5.1.4. In-vitro Diagnostics (IVD)
    • 7.5.1.5. Minimally Invasive Surgery Devices
    • 7.5.1.6. Wound Management
    • 7.5.1.7. Diabetes Care Devices
    • 7.5.1.8. Ophthalmic Devices
    • 7.5.1.9. Nephrology Devices
    • 7.5.1.10. Dental Devices
    • 7.5.1.11. General Surgery
    • 7.5.1.12. Others
  • 7.5.2. Market Analysis, Insights and Forecast - By End User
    • 7.5.2.1. Hospitals & ASCs
    • 7.5.2.2. Clinics
    • 7.5.2.3. Others
• 7.6. France Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.6.1. Market Analysis, Insights and Forecast - By Type
    • 7.6.1.1. Orthopedic Devices
    • 7.6.1.2. Cardiovascular Devices
    • 7.6.1.3. Diagnostic Imaging Devices
    • 7.6.1.4. In-vitro Diagnostics (IVD)
    • 7.6.1.5. Minimally Invasive Surgery Devices
    • 7.6.1.6. Wound Management
    • 7.6.1.7. Diabetes Care Devices
    • 7.6.1.8. Ophthalmic Devices
    • 7.6.1.9. Nephrology Devices
    • 7.6.1.10. Dental Devices
    • 7.6.1.11. General Surgery
    • 7.6.1.12. Others
  • 7.6.2. Market Analysis, Insights and Forecast - By End User
    • 7.6.2.1. Hospitals & ASCs
    • 7.6.2.2. Clinics
    • 7.6.2.3. Others
• 7.7. Italy Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.7.1. Market Analysis, Insights and Forecast - By Type
    • 7.7.1.1. Orthopedic Devices
    • 7.7.1.2. Cardiovascular Devices
    • 7.7.1.3. Diagnostic Imaging Devices
    • 7.7.1.4. In-vitro Diagnostics (IVD)
    • 7.7.1.5. Minimally Invasive Surgery Devices
    • 7.7.1.6. Wound Management
    • 7.7.1.7. Diabetes Care Devices
    • 7.7.1.8. Ophthalmic Devices
    • 7.7.1.9. Nephrology Devices
    • 7.7.1.10. Dental Devices
    • 7.7.1.11. General Surgery
    • 7.7.1.12. Others
  • 7.7.2. Market Analysis, Insights and Forecast - By End User
    • 7.7.2.1. Hospitals & ASCs
    • 7.7.2.2. Clinics
    • 7.7.2.3. Others
• 7.8. Spain Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.8.1. Market Analysis, Insights and Forecast - By Type
    • 7.8.1.1. Orthopedic Devices
    • 7.8.1.2. Cardiovascular Devices
    • 7.8.1.3. Diagnostic Imaging Devices
    • 7.8.1.4. In-vitro Diagnostics (IVD)
    • 7.8.1.5. Minimally Invasive Surgery Devices
    • 7.8.1.6. Wound Management
    • 7.8.1.7. Diabetes Care Devices
    • 7.8.1.8. Ophthalmic Devices
    • 7.8.1.9. Nephrology Devices
    • 7.8.1.10. Dental Devices
    • 7.8.1.11. General Surgery
    • 7.8.1.12. Others
  • 7.8.2. Market Analysis, Insights and Forecast - By End User
    • 7.8.2.1. Hospitals & ASCs
    • 7.8.2.2. Clinics
    • 7.8.2.3. Others
• 7.9. Rest of Europe Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 7.9.1. Market Analysis, Insights and Forecast - By Type
    • 7.9.1.1. Orthopedic Devices
    • 7.9.1.2. Cardiovascular Devices
    • 7.9.1.3. Diagnostic Imaging Devices
    • 7.9.1.4. In-vitro Diagnostics (IVD)
    • 7.9.1.5. Minimally Invasive Surgery Devices
    • 7.9.1.6. Wound Management
    • 7.9.1.7. Diabetes Care Devices
    • 7.9.1.8. Ophthalmic Devices
    • 7.9.1.9. Nephrology Devices
    • 7.9.1.10. Dental Devices
    • 7.9.1.11. General Surgery
    • 7.9.1.12. Others
  • 7.9.2. Market Analysis, Insights and Forecast - By End User
    • 7.9.2.1. Hospitals & ASCs
    • 7.9.2.2. Clinics
    • 7.9.2.3. Others

8. Asia Pacific Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Orthopedic Devices
  • 8.1.2. Cardiovascular Devices
  • 8.1.3. Diagnostic Imaging Devices
  • 8.1.4. In-vitro Diagnostics (IVD)
  • 8.1.5. Minimally Invasive Surgery Devices
  • 8.1.6. Wound Management
  • 8.1.7. Diabetes Care Devices
  • 8.1.8. Ophthalmic Devices
  • 8.1.9. Nephrology Devices
  • 8.1.10. Dental Devices
  • 8.1.11. General Surgery
  • 8.1.12. Others
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Hospitals & ASCs
  • 8.2.2. Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific
• 8.4. China Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.4.1. Market Analysis, Insights and Forecast - By Type
    • 8.4.1.1. Orthopedic Devices
    • 8.4.1.2. Cardiovascular Devices
    • 8.4.1.3. Diagnostic Imaging Devices
    • 8.4.1.4. In-vitro Diagnostics (IVD)
    • 8.4.1.5. Minimally Invasive Surgery Devices
    • 8.4.1.6. Wound Management
    • 8.4.1.7. Diabetes Care Devices
    • 8.4.1.8. Ophthalmic Devices
    • 8.4.1.9. Nephrology Devices
    • 8.4.1.10. Dental Devices
    • 8.4.1.11. General Surgery
    • 8.4.1.12. Others
  • 8.4.2. Market Analysis, Insights and Forecast - By End User
    • 8.4.2.1. Hospitals & ASCs
    • 8.4.2.2. Clinics
    • 8.4.2.3. Others
• 8.5. Japan Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.5.1. Market Analysis, Insights and Forecast - By Type
    • 8.5.1.1. Orthopedic Devices
    • 8.5.1.2. Cardiovascular Devices
    • 8.5.1.3. Diagnostic Imaging Devices
    • 8.5.1.4. In-vitro Diagnostics (IVD)
    • 8.5.1.5. Minimally Invasive Surgery Devices
    • 8.5.1.6. Wound Management
    • 8.5.1.7. Diabetes Care Devices
    • 8.5.1.8. Ophthalmic Devices
    • 8.5.1.9. Nephrology Devices
    • 8.5.1.10. Dental Devices
    • 8.5.1.11. General Surgery
    • 8.5.1.12. Others
  • 8.5.2. Market Analysis, Insights and Forecast - By End User
    • 8.5.2.1. Hospitals & ASCs
    • 8.5.2.2. Clinics
    • 8.5.2.3. Others
• 8.6. India Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.6.1. Market Analysis, Insights and Forecast - By Type
    • 8.6.1.1. Orthopedic Devices
    • 8.6.1.2. Cardiovascular Devices
    • 8.6.1.3. Diagnostic Imaging Devices
    • 8.6.1.4. In-vitro Diagnostics (IVD)
    • 8.6.1.5. Minimally Invasive Surgery Devices
    • 8.6.1.6. Wound Management
    • 8.6.1.7. Diabetes Care Devices
    • 8.6.1.8. Ophthalmic Devices
    • 8.6.1.9. Nephrology Devices
    • 8.6.1.10. Dental Devices
    • 8.6.1.11. General Surgery
    • 8.6.1.12. Others
  • 8.6.2. Market Analysis, Insights and Forecast - By End User
    • 8.6.2.1. Hospitals & ASCs
    • 8.6.2.2. Clinics
    • 8.6.2.3. Others
• 8.7. Australia Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.7.1. Market Analysis, Insights and Forecast - By Type
    • 8.7.1.1. Orthopedic Devices
    • 8.7.1.2. Cardiovascular Devices
    • 8.7.1.3. Diagnostic Imaging Devices
    • 8.7.1.4. In-vitro Diagnostics (IVD)
    • 8.7.1.5. Minimally Invasive Surgery Devices
    • 8.7.1.6. Wound Management
    • 8.7.1.7. Diabetes Care Devices
    • 8.7.1.8. Ophthalmic Devices
    • 8.7.1.9. Nephrology Devices
    • 8.7.1.10. Dental Devices
    • 8.7.1.11. General Surgery
    • 8.7.1.12. Others
  • 8.7.2. Market Analysis, Insights and Forecast - By End User
    • 8.7.2.1. Hospitals & ASCs
    • 8.7.2.2. Clinics
    • 8.7.2.3. Others
• 8.8. Rest of Asia Pacific Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 8.8.1. Market Analysis, Insights and Forecast - By Type
    • 8.8.1.1. Orthopedic Devices
    • 8.8.1.2. Cardiovascular Devices
    • 8.8.1.3. Diagnostic Imaging Devices
    • 8.8.1.4. In-vitro Diagnostics (IVD)
    • 8.8.1.5. Minimally Invasive Surgery Devices
    • 8.8.1.6. Wound Management
    • 8.8.1.7. Diabetes Care Devices
    • 8.8.1.8. Ophthalmic Devices
    • 8.8.1.9. Nephrology Devices
    • 8.8.1.10. Dental Devices
    • 8.8.1.11. General Surgery
    • 8.8.1.12. Others
  • 8.8.2. Market Analysis, Insights and Forecast - By End User
    • 8.8.2.1. Hospitals & ASCs
    • 8.8.2.2. Clinics
    • 8.8.2.3. Others

9. Latin America Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Orthopedic Devices
  • 9.1.2. Cardiovascular Devices
  • 9.1.3. Diagnostic Imaging Devices
  • 9.1.4. In-vitro Diagnostics (IVD)
  • 9.1.5. Minimally Invasive Surgery Devices
  • 9.1.6. Wound Management
  • 9.1.7. Diabetes Care Devices
  • 9.1.8. Ophthalmic Devices
  • 9.1.9. Nephrology Devices
  • 9.1.10. Dental Devices
  • 9.1.11. General Surgery
  • 9.1.12. Others
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Hospitals & ASCs
  • 9.2.2. Clinics
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America
• 9.4. Brazil Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.4.1. Market Analysis, Insights and Forecast - By Type
    • 9.4.1.1. Orthopedic Devices
    • 9.4.1.2. Cardiovascular Devices
    • 9.4.1.3. Diagnostic Imaging Devices
    • 9.4.1.4. In-vitro Diagnostics (IVD)
    • 9.4.1.5. Minimally Invasive Surgery Devices
    • 9.4.1.6. Wound Management
    • 9.4.1.7. Diabetes Care Devices
    • 9.4.1.8. Ophthalmic Devices
    • 9.4.1.9. Nephrology Devices
    • 9.4.1.10. Dental Devices
    • 9.4.1.11. General Surgery
    • 9.4.1.12. Others
  • 9.4.2. Market Analysis, Insights and Forecast - By End User
    • 9.4.2.1. Hospitals & ASCs
    • 9.4.2.2. Clinics
    • 9.4.2.3. Others
• 9.5. Mexico Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.5.1. Market Analysis, Insights and Forecast - By Type
    • 9.5.1.1. Orthopedic Devices
    • 9.5.1.2. Cardiovascular Devices
    • 9.5.1.3. Diagnostic Imaging Devices
    • 9.5.1.4. In-vitro Diagnostics (IVD)
    • 9.5.1.5. Minimally Invasive Surgery Devices
    • 9.5.1.6. Wound Management
    • 9.5.1.7. Diabetes Care Devices
    • 9.5.1.8. Ophthalmic Devices
    • 9.5.1.9. Nephrology Devices
    • 9.5.1.10. Dental Devices
    • 9.5.1.11. General Surgery
    • 9.5.1.12. Others
  • 9.5.2. Market Analysis, Insights and Forecast - By End User
    • 9.5.2.1. Hospitals & ASCs
    • 9.5.2.2. Clinics
    • 9.5.2.3. Others
• 9.6. Rest of Latin America Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 9.6.1. Market Analysis, Insights and Forecast - By Type
    • 9.6.1.1. Orthopedic Devices
    • 9.6.1.2. Cardiovascular Devices
    • 9.6.1.3. Diagnostic Imaging Devices
    • 9.6.1.4. In-vitro Diagnostics (IVD)
    • 9.6.1.5. Minimally Invasive Surgery Devices
    • 9.6.1.6. Wound Management
    • 9.6.1.7. Diabetes Care Devices
    • 9.6.1.8. Ophthalmic Devices
    • 9.6.1.9. Nephrology Devices
    • 9.6.1.10. Dental Devices
    • 9.6.1.11. General Surgery
    • 9.6.1.12. Others
  • 9.6.2. Market Analysis, Insights and Forecast - By End User
    • 9.6.2.1. Hospitals & ASCs
    • 9.6.2.2. Clinics
    • 9.6.2.3. Others

10. Middle East & Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Orthopedic Devices
  • 10.1.2. Cardiovascular Devices
  • 10.1.3. Diagnostic Imaging Devices
  • 10.1.4. In-vitro Diagnostics (IVD)
  • 10.1.5. Minimally Invasive Surgery Devices
  • 10.1.6. Wound Management
  • 10.1.7. Diabetes Care Devices
  • 10.1.8. Ophthalmic Devices
  • 10.1.9. Nephrology Devices
  • 10.1.10. Dental Devices
  • 10.1.11. General Surgery
  • 10.1.12. Others
• 10.2. Market Analysis, Insights and Forecast - By End User
  • 10.2.1. Hospitals & ASCs
  • 10.2.2. Clinics
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa
• 10.4. GCC Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.4.1. Market Analysis, Insights and Forecast - By Type
    • 10.4.1.1. Orthopedic Devices
    • 10.4.1.2. Cardiovascular Devices
    • 10.4.1.3. Diagnostic Imaging Devices
    • 10.4.1.4. In-vitro Diagnostics (IVD)
    • 10.4.1.5. Minimally Invasive Surgery Devices
    • 10.4.1.6. Wound Management
    • 10.4.1.7. Diabetes Care Devices
    • 10.4.1.8. Ophthalmic Devices
    • 10.4.1.9. Nephrology Devices
    • 10.4.1.10. Dental Devices
    • 10.4.1.11. General Surgery
    • 10.4.1.12. Others
  • 10.4.2. Market Analysis, Insights and Forecast - By End User
    • 10.4.2.1. Hospitals & ASCs
    • 10.4.2.2. Clinics
    • 10.4.2.3. Others
• 10.5. South Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.5.1. Market Analysis, Insights and Forecast - By Type
    • 10.5.1.1. Orthopedic Devices
    • 10.5.1.2. Cardiovascular Devices
    • 10.5.1.3. Diagnostic Imaging Devices
    • 10.5.1.4. In-vitro Diagnostics (IVD)
    • 10.5.1.5. Minimally Invasive Surgery Devices
    • 10.5.1.6. Wound Management
    • 10.5.1.7. Diabetes Care Devices
    • 10.5.1.8. Ophthalmic Devices
    • 10.5.1.9. Nephrology Devices
    • 10.5.1.10. Dental Devices
    • 10.5.1.11. General Surgery
    • 10.5.1.12. Others
  • 10.5.2. Market Analysis, Insights and Forecast - By End User
    • 10.5.2.1. Hospitals & ASCs
    • 10.5.2.2. Clinics
    • 10.5.2.3. Others
• 10.6. Rest of Middle East & Africa Medical Devices Market Analysis, Insights and Forecast, 2021-2034
  • 10.6.1. Market Analysis, Insights and Forecast - By Type
    • 10.6.1.1. Orthopedic Devices
    • 10.6.1.2. Cardiovascular Devices
    • 10.6.1.3. Diagnostic Imaging Devices
    • 10.6.1.4. In-vitro Diagnostics (IVD)
    • 10.6.1.5. Minimally Invasive Surgery Devices
    • 10.6.1.6. Wound Management
    • 10.6.1.7. Diabetes Care Devices
    • 10.6.1.8. Ophthalmic Devices
    • 10.6.1.9. Nephrology Devices
    • 10.6.1.10. Dental Devices
    • 10.6.1.11. General Surgery
    • 10.6.1.12. Others
  • 10.6.2. Market Analysis, Insights and Forecast - By End User
    • 10.6.2.1. Hospitals & ASCs
    • 10.6.2.2. Clinics
    • 10.6.2.3. Others

11. Analysis of the High-Medium-Low Impact of COVID-19

• 11.1. Medical Device Market Segments
  • 11.1.1. High Impact
  • 11.1.2. Medium Impact
  • 11.1.3. Low Impact
• 11.2. Key Medical Device Companies
  • 11.2.1. High Impact
  • 11.2.2. Medium Impact
  • 11.2.3. Low Impact

12. Competitive Analysis

• 12.1. Global Market Share Analysis (2025)
• 12.2. Profiles of Players Operating in the Market
  • 12.2.1. Medtronic
    • 12.2.1.1. Overview
    • 12.2.1.2. Products
    • 12.2.1.3. SWOT Analysis
    • 12.2.1.4. Recent Developments
    • 12.2.1.5. Strategies
    • 12.2.1.6. Financials (Based on Availability)
  • 12.2.2. Abbott
    • 12.2.2.1. Overview
    • 12.2.2.2. Products
    • 12.2.2.3. SWOT Analysis
    • 12.2.2.4. Recent Developments
    • 12.2.2.5. Strategies
    • 12.2.2.6. Financials (Based on Availability)
  • 12.2.3. Siemens Healthineers AG
    • 12.2.3.1. Overview
    • 12.2.3.2. Products
    • 12.2.3.3. SWOT Analysis
    • 12.2.3.4. Recent Developments
    • 12.2.3.5. Strategies
    • 12.2.3.6. Financials (Based on Availability)
  • 12.2.4. Johnson & Johnson Services, Inc.
    • 12.2.4.1. Overview
    • 12.2.4.2. Products
    • 12.2.4.3. SWOT Analysis
    • 12.2.4.4. Recent Developments
    • 12.2.4.5. Strategies
    • 12.2.4.6. Financials (Based on Availability)
  • 12.2.5. Koninklijke Philips N.V.
    • 12.2.5.1. Overview
    • 12.2.5.2. Products
    • 12.2.5.3. SWOT Analysis
    • 12.2.5.4. Recent Developments
    • 12.2.5.5. Strategies
    • 12.2.5.6. Financials (Based on Availability)
  • 12.2.6. Stryker
    • 12.2.6.1. Overview
    • 12.2.6.2. Products
    • 12.2.6.3. SWOT Analysis
    • 12.2.6.4. Recent Developments
    • 12.2.6.5. Strategies
    • 12.2.6.6. Financials (Based on Availability)
  • 12.2.7. F. Hoffmann-La Roche AG
    • 12.2.7.1. Overview
    • 12.2.7.2. Products
    • 12.2.7.3. SWOT Analysis
    • 12.2.7.4. Recent Developments
    • 12.2.7.5. Strategies
    • 12.2.7.6. Financials (Based on Availability)
  • 12.2.8. BD
    • 12.2.8.1. Overview
    • 12.2.8.2. Products
    • 12.2.8.3. SWOT Analysis
    • 12.2.8.4. Recent Developments
    • 12.2.8.5. Strategies
    • 12.2.8.6. Financials (Based on Availability)
  • 12.2.9. GE Healthcare
    • 12.2.9.1. Overview
    • 12.2.9.2. Products
    • 12.2.9.3. SWOT Analysis
    • 12.2.9.4. Recent Developments
    • 12.2.9.5. Strategies
    • 12.2.9.6. Financials (Based on Availability)
  • 12.2.10. Boston Scientific Corporation
    • 12.2.10.1. Overview
    • 12.2.10.2. Products
    • 12.2.10.3. SWOT Analysis
    • 12.2.10.4. Recent Developments
    • 12.2.10.5. Strategies
    • 12.2.10.6. Financials (Based on Availability)
  • 12.2.11. Fresenius Medical Care AG & Co. KGaA
    • 12.2.11.1. Overview
    • 12.2.11.2. Products
    • 12.2.11.3. SWOT Analysis
    • 12.2.11.4. Recent Developments
    • 12.2.11.5. Strategies
    • 12.2.11.6. Financials (Based on Availability)

관련자료